Varayu Prachayakul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Varayu Prachayakul has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Pitulak Aswakul
Liver and Digestive Institute, Samitivej Sukhumvit Hospital, Bangkok, Thailand
10 shared publications- Arunchai Chang
Division of Gastroenterology, Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand
7 shared publications Manus Rugivarodom
Siriraj Gastrointestinal Endoscopy Center, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
4 shared publicationsArunchai Chang
Division of Gastroenterology, Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand
3 shared publicationsBancha Ovartlarnporn
NKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand
3 shared publications- Keerati Akarapatima
Division of Gastroenterology, Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand
3 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published byĀ Springer NatureĀ inĀ Scientific Reports
- Vol.Ā 16 Ā (1)
Association of pre-endoscopic fresh frozen plasma transfusion with clinical outcomes in patients with acute upper gastrointestinal bleeding and mild coagulopathy: a two-center retrospective cohort study
The clinical benefit of fresh frozen plasma (FFP) transfusion prior to endoscopy in patients with acute upper gastrointestinal bleeding (AUGIB) and mild coagulopathy remains uncertain. We evaluated the association between pre-endoscopic FFP transfusion and clinical outcomes in patients with AUGIB and an international normalized ratio (INR) of 1.5ā2.5. We conducted a retrospective two-center cohort study including adult patients admitted with AUGIB and INR 1.5ā2.5 at two tertiary referral hospitals in Thailand between 2016 and 2020. Patients were categorized according to receipt of pre-endoscopic FFP transfusion. Multivariable logistic regression analyses were performed using baseline covariates and bleeding severity scores. An exploratory composite in-hospital major adverse event endpoint was evaluated to improve model stability. Among 244 patients (158 received FFP; 86 did not), those receiving pre-endoscopic FFP had higher crude rates of 30-day all-cause mortality (23.4% vs. 11.6%), in-hospital mortality (24.1% vs. 7.0%), pulmonary edema (23.4% vs. 4.7%), and the composite in-hospital major adverse event endpoint (40.5% vs. 10.5%) (all p < 0.01). After multivariable adjustment, pre-endoscopic FFP transfusion remained associated with the composite endpoint (adjusted odds ratio [aOR] 5.28; 95% confidence interval [CI], 2.17ā12.82), in-hospital mortality (aOR 5.36; 95% CI, 1.87ā15.37), pulmonary edema (aOR 3.85; 95% CI, 1.21ā12.26), and 30-day mortality (aOR 2.69; 95% CI, 1.09ā6.66). In subgroup analyses, these associations were more consistent among patients with variceal bleeding. In patients with AUGIB and mildly elevated INR, pre-endoscopic FFP transfusion was associated with higher mortality and pulmonary complications, particularly in those with variceal bleeding. Given the retrospective design and potential for residual confounding, these findings should be interpreted with caution. Nevertheless, these findings support consideration of a more selective, context-based approach to plasma transfusion and highlight the need for prospective studies to inform evidence-based transfusion strategies.
- 28 February 2026
- Published byĀ Springer NatureĀ inĀ Scientific Reports
- Vol.Ā 16 Ā (1)
Open AccessAssociation of pre-endoscopic fresh frozen plasma transfusion with clinical outcomes in patients with acute upper gastrointestinal bleeding and mild coagulopathy: a two-center retrospective cohort study
The clinical benefit of fresh frozen plasma (FFP) transfusion prior to endoscopy in patients with acute upper gastrointestinal bleeding (AUGIB) and mild coagulopathy remains uncertain. We evaluated the association between pre-endoscopic FFP transfusion and clinical outcomes in patients with AUGIB and an international normalized ratio (INR) of 1.5ā2.5. We conducted a retrospective two-center cohort study including adult patients admitted with AUGIB and INR 1.5ā2.5 at two tertiary referral hospitals in Thailand between 2016 and 2020. Patients were categorized according to receipt of pre-endoscopic FFP transfusion. Multivariable logistic regression analyses were performed using baseline covariates and bleeding severity scores. An exploratory composite in-hospital major adverse event endpoint was evaluated to improve model stability. Among 244 patients (158 received FFP; 86 did not), those receiving pre-endoscopic FFP had higher crude rates of 30-day all-cause mortality (23.4% vs. 11.6%), in-hospital mortality (24.1% vs. 7.0%), pulmonary edema (23.4% vs. 4.7%), and the composite in-hospital major adverse event endpoint (40.5% vs. 10.5%) (all p < 0.01). After multivariable adjustment, pre-endoscopic FFP transfusion remained associated with the composite endpoint (adjusted odds ratio [aOR] 5.28; 95% confidence interval [CI], 2.17ā12.82), in-hospital mortality (aOR 5.36; 95% CI, 1.87ā15.37), pulmonary edema (aOR 3.85; 95% CI, 1.21ā12.26), and 30-day mortality (aOR 2.69; 95% CI, 1.09ā6.66). In subgroup analyses, these associations were more consistent among patients with variceal bleeding. In patients with AUGIB and mildly elevated INR, pre-endoscopic FFP transfusion was associated with higher mortality and pulmonary complications, particularly in those with variceal bleeding. Given the retrospective design and potential for residual confounding, these findings should be interpreted with caution. Nevertheless, these findings support consideration of a more selective, context-based approach to plasma transfusion and highlight the need for prospective studies to inform evidence-based transfusion strategies.
- Open Access
- 17 February 2025
- Published byĀ Springer NatureĀ inĀ BMC Gastroenterology
- Vol.Ā 25 Ā (1) , 1-10
Impact of duration to endoscopy in patients with non-variceal upper gastrointestinal bleeding: propensity score matching analysis of real-world data from Thailand
The findings on mortality, rebleeding rate, and hospital stay in patients who underwent early vs. late endoscopy are conflicting. We aimed to compare in-hospital outcomes and medical resource use in patients with acute non-variceal upper gastrointestinal bleeding. We retrospectively reviewed the medical records of patients with acute non-variceal upper gastrointestinal bleeding who underwent early or late endoscopy between 2016 and 2019. The primary outcome was in-hospital mortality. The secondary outcomes were the need for packed red blood cells and number of transfusions, the proportion of lesions with high-risk stigmata, endoscopic and additional hemostasis, in-hospital rebleeding, duration of stay, and admission cost. Statistical analysis was performed using Pearsonās chi-squared or Fisherās exact test for categorical variables, Studentās t-test, and Wilcoxon rank-sum test for continuous variables. Early and late endoscopies were performed on 451 and 279 patients, respectively. After 1:1 propensity score matching, 278 patients from each group were included, and patientsā baseline characteristics were similar in the matched groups. Compared with the late group, the early group had a significantly increased rate of endoscopic hemostasis (22.7% vs. 13.7%, P = 0.006) and a low rate of packed red blood cell transfusion (53.6% vs. 61.9%, P = 0.048). Duration of stay and admission costs were significantly higher in the late group than in the early group (all P < 0.05). After adjusting for confounding factors, early endoscopy was positively associated with ulcers with high-risk stigmata (adjusted odds ratio = 1.83, P = 0.023) and endoscopic hemostasis (adjusted odds ratio = 1.97, P = 0.004). It was negatively associated with the need for packed red blood cell transfusion (adjusted odds ratio = 0.62, P = 0.017) and duration of stay (adjusted coefficient=-0.10, P < 0.001) with no impact on in-hospital mortality, rebleeding, or radiological interventions. The timing of endoscopy does not affect in-hospital mortality or rebleeding rate. This study supports using early endoscopy in patients with acute non-variceal upper gastrointestinal bleeding based on the potential benefits and feasibility of medical resource use.
- 17 February 2025
- Published byĀ Springer NatureĀ inĀ BMC Gastroenterology
- Vol.Ā 25 Ā (1) , 1-10
Open AccessImpact of duration to endoscopy in patients with non-variceal upper gastrointestinal bleeding: propensity score matching analysis of real-world data from Thailand
The findings on mortality, rebleeding rate, and hospital stay in patients who underwent early vs. late endoscopy are conflicting. We aimed to compare in-hospital outcomes and medical resource use in patients with acute non-variceal upper gastrointestinal bleeding. We retrospectively reviewed the medical records of patients with acute non-variceal upper gastrointestinal bleeding who underwent early or late endoscopy between 2016 and 2019. The primary outcome was in-hospital mortality. The secondary outcomes were the need for packed red blood cells and number of transfusions, the proportion of lesions with high-risk stigmata, endoscopic and additional hemostasis, in-hospital rebleeding, duration of stay, and admission cost. Statistical analysis was performed using Pearsonās chi-squared or Fisherās exact test for categorical variables, Studentās t-test, and Wilcoxon rank-sum test for continuous variables. Early and late endoscopies were performed on 451 and 279 patients, respectively. After 1:1 propensity score matching, 278 patients from each group were included, and patientsā baseline characteristics were similar in the matched groups. Compared with the late group, the early group had a significantly increased rate of endoscopic hemostasis (22.7% vs. 13.7%, P = 0.006) and a low rate of packed red blood cell transfusion (53.6% vs. 61.9%, P = 0.048). Duration of stay and admission costs were significantly higher in the late group than in the early group (all P < 0.05). After adjusting for confounding factors, early endoscopy was positively associated with ulcers with high-risk stigmata (adjusted odds ratio = 1.83, P = 0.023) and endoscopic hemostasis (adjusted odds ratio = 1.97, P = 0.004). It was negatively associated with the need for packed red blood cell transfusion (adjusted odds ratio = 0.62, P = 0.017) and duration of stay (adjusted coefficient=-0.10, P < 0.001) with no impact on in-hospital mortality, rebleeding, or radiological interventions. The timing of endoscopy does not affect in-hospital mortality or rebleeding rate. This study supports using early endoscopy in patients with acute non-variceal upper gastrointestinal bleeding based on the potential benefits and feasibility of medical resource use.
- 27 July 2023
- Published byĀ S. Karger AGĀ inĀ Digestion
- Vol.Ā 105 Ā (1) , 62-68
Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire Survey
Introduction: Diagnostic and therapeutic methods for colorectal cancer (CRC) have advanced; however, they may be inaccessible worldwide, and their widespread use is challenging. This questionnaire survey investigates the current status of diagnosis and treatment of early-stage CRC in Asian countries. Methods: Responses to the questionnaire were obtained from 213 doctors at different institutions in 8 countries and regions. The questionnaire consisted of 39 questions on the following four topics: noninvasive diagnosis other than endoscopy (6 questions), diagnosis by magnification and image-enhanced endoscopy (IEE) including artificial intelligence (AI) (10 questions), endoscopic submucosal dissection (ESD), proper use among other therapeutic methods (11 questions), and pathologic diagnosis and surveillance (12 questions). Results: Although 101 of 213 respondents were affiliated with academic hospitals, there were disparities among countries and regions in the dissemination of advanced technologies, such as IEE, AI, and ESD. The NICE classification is widely used for the diagnosis of colorectal tumors using IEE, while the JNET classification with magnification was used in countries such as Japan (65/70, 92.9%) and China (16/22, 72.7%). Of the 211 respondents, 208 (98.6%) assumed that en bloc resection should be achieved for carcinomas, and 180 of 212 (84.9%) believed that ESD was the most suitable in cases with a diameter larger than 2 cm. However, colorectal ESD is not widespread in countries such as Thailand, the Philippines, and Indonesia. Conclusion: The promotion of advanced technologies and education should be continual to enable more people to benefit from them.
- 27 July 2023
- Published byĀ S. Karger AGĀ inĀ Digestion
- Vol.Ā 105 Ā (1) , 62-68
Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire Survey
Introduction: Diagnostic and therapeutic methods for colorectal cancer (CRC) have advanced; however, they may be inaccessible worldwide, and their widespread use is challenging. This questionnaire survey investigates the current status of diagnosis and treatment of early-stage CRC in Asian countries. Methods: Responses to the questionnaire were obtained from 213 doctors at different institutions in 8 countries and regions. The questionnaire consisted of 39 questions on the following four topics: noninvasive diagnosis other than endoscopy (6 questions), diagnosis by magnification and image-enhanced endoscopy (IEE) including artificial intelligence (AI) (10 questions), endoscopic submucosal dissection (ESD), proper use among other therapeutic methods (11 questions), and pathologic diagnosis and surveillance (12 questions). Results: Although 101 of 213 respondents were affiliated with academic hospitals, there were disparities among countries and regions in the dissemination of advanced technologies, such as IEE, AI, and ESD. The NICE classification is widely used for the diagnosis of colorectal tumors using IEE, while the JNET classification with magnification was used in countries such as Japan (65/70, 92.9%) and China (16/22, 72.7%). Of the 211 respondents, 208 (98.6%) assumed that en bloc resection should be achieved for carcinomas, and 180 of 212 (84.9%) believed that ESD was the most suitable in cases with a diameter larger than 2 cm. However, colorectal ESD is not widespread in countries such as Thailand, the Philippines, and Indonesia. Conclusion: The promotion of advanced technologies and education should be continual to enable more people to benefit from them.
- Open Access
- 4 January 2023
- Published byĀ Georg Thieme Verlag KGĀ inĀ Endoscopy
- Vol.Ā 55 Ā (S 01) , E1083-E1084
Percutaneous transhepatic digital single-operator cholangioscopy-guided laser lithotripsy in treating difficult intrahepatic duct stone in surgically altered anatomy
Endoscopic intrahepatic duct (IHD) stone management in patients with surgically altered anatomy is a major technical challenge [1] [2]. A 74-year-old man with a history of hilar resection with Roux-en-Y hepaticojejunostomy from a hilar tumor presented with a history of cholangitis. Magnetic resonance imaging showed multiple large left IHD stones ([Fig. 1]). Despite balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography and percutaneous cholangioplasty, residual impacted IHD stones were present within the left IHD proximal to the stricture ([Fig. 2]). After multidisciplinary team discussion, the patient underwent percutaneous transhepatic cholangioscopy-guided laser lithotripsy ([Video 1]). Video 1 Presentation of the case and percutaneous transhepatic cholangioscopy-guided laser lithotripsy. The percutaneous tract was dilated up to 14 Fr and left to mature for 8 weeks. General anesthesia and prophylactic antibiotic administration were performed. The guidewire (0.035-inch, Visiglide; Olympus, Tokyo, Japan) via the percutaneous transhepatic biliary drainage catheter (14 Fr, biliary catheter; Cook Medical, Bloomington, Indiana, USA) was inserted into the left IHD to reach the jejunum beyond the anastomosis. The catheter was then removed. A novel short-length (65 cm) cholangioscope (SpyGlass Discover Digital Catheter; Boston Scientific, Marlborough, Massachusetts, USA) was introduced over the wire into the IHD ([Fig. 3]). The previously placed stent was removed using a SpySnare (Boston Scientific). A laser fiber (Jena Surgical, Brüsseler, Germany) was introduced. We performed laser lithotripsy from the central portion and moved upstream to the periphery. Stone fragments were flushed downstream into the jejunum until completely cleared. The patient recovered well and was discharged on Day 2 after the procedure. For technical consideration, the percutaneous access tract of at least 12 Fr in size should be left for at least 4ā8 weeks to ensure tract maturation. The short-length cholangioscope was preferable for percutaneous access owing to the ease of scope maneuverability and high scope stability, as well as low risk of endoscopy-related infection. Endoscopy_UCTN_Code_TTT_1AR_2AH Article published online: 27 September 2023 Ā© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG RüdigerstraĆe 14, 70469 Stuttgart, Germany
- 4 January 2023
- Published byĀ Georg Thieme Verlag KGĀ inĀ Endoscopy
- Vol.Ā 55 Ā (S 01) , E1083-E1084
Open AccessPercutaneous transhepatic digital single-operator cholangioscopy-guided laser lithotripsy in treating difficult intrahepatic duct stone in surgically altered anatomy
Endoscopic intrahepatic duct (IHD) stone management in patients with surgically altered anatomy is a major technical challenge [1] [2]. A 74-year-old man with a history of hilar resection with Roux-en-Y hepaticojejunostomy from a hilar tumor presented with a history of cholangitis. Magnetic resonance imaging showed multiple large left IHD stones ([Fig. 1]). Despite balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography and percutaneous cholangioplasty, residual impacted IHD stones were present within the left IHD proximal to the stricture ([Fig. 2]). After multidisciplinary team discussion, the patient underwent percutaneous transhepatic cholangioscopy-guided laser lithotripsy ([Video 1]). Video 1 Presentation of the case and percutaneous transhepatic cholangioscopy-guided laser lithotripsy. The percutaneous tract was dilated up to 14 Fr and left to mature for 8 weeks. General anesthesia and prophylactic antibiotic administration were performed. The guidewire (0.035-inch, Visiglide; Olympus, Tokyo, Japan) via the percutaneous transhepatic biliary drainage catheter (14 Fr, biliary catheter; Cook Medical, Bloomington, Indiana, USA) was inserted into the left IHD to reach the jejunum beyond the anastomosis. The catheter was then removed. A novel short-length (65 cm) cholangioscope (SpyGlass Discover Digital Catheter; Boston Scientific, Marlborough, Massachusetts, USA) was introduced over the wire into the IHD ([Fig. 3]). The previously placed stent was removed using a SpySnare (Boston Scientific). A laser fiber (Jena Surgical, Brüsseler, Germany) was introduced. We performed laser lithotripsy from the central portion and moved upstream to the periphery. Stone fragments were flushed downstream into the jejunum until completely cleared. The patient recovered well and was discharged on Day 2 after the procedure. For technical consideration, the percutaneous access tract of at least 12 Fr in size should be left for at least 4ā8 weeks to ensure tract maturation. The short-length cholangioscope was preferable for percutaneous access owing to the ease of scope maneuverability and high scope stability, as well as low risk of endoscopy-related infection. Endoscopy_UCTN_Code_TTT_1AR_2AH Article published online: 27 September 2023 Ā© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG RüdigerstraĆe 14, 70469 Stuttgart, Germany
- 19 February 2022
- Published byĀ Springer NatureĀ inĀ Surgical Endoscopy
- Vol.Ā 36 Ā (8) , 5743-5752
Comparison of blue laser imaging and narrow band imaging for the differentiation of diminutive colorectal polyps: A randomized controlled trial
Background To compare the diagnostic efficacy of blue laser imaging (BLI)- bright and narrow band imaging (NBI) modes of image enhanced endoscopy (IEE) in differentiating neoplastic and non-neoplastic lesions of diminutive colorectal polyps. Methods We conducted a prospective randomized controlled trial from September 2015 to July 2016. The participants were randomly assigned (1:1) for colonoscopy with polyp classification under NBI or BLI-bright mode without magnification. Histopathologic diagnosis was used as the gold standard. Results Three hundred and twenty-four diminutive polyps in 164 patients were included for analysis (BLI: 162 polyps in 73 patients, NBI: 162 polyps in 91 patients). These polyps were located at colon proximal to sigmoid (61.1 and 58.0%) and rectosigmoid colon (38.9 and 42.0%) in the BLI and NBI groups, respectively. Most polyps (71.9%) were adenomatous with one malignant polyp (0.3%). BLI achieved 86.4% accuracy, 98.3% sensitivity, 55.6% specificity, 85.2% positive predictive value (PPV), and 92.6% negative predictive value (NPV), similar to NBI which exhibited 90.1% accuracy, 99.1% sensitivity, 67.4% specificity, 88.5% PPV, and 96.9% NPV in the diagnosis of adenomatous polyps. Based on the location of the polyp, both modes of IEE provided ā„ 95% NPV for diagnosis of adenomatous polyps at the rectosigmoid colon. Conclusions BLI-bright and NBI modes of IEE have similar accuracy in differentiation between neoplastic and non-neoplastic lesions of diminutive polyps. Both modes provided ā„ 90% NPV which allows for the adaptation of the American Society of Gastrointestinal Endoscopy ādiagnose-and-leaveā recommended strategy for diminutive polyps at the rectosigmoid colon.
- 19 February 2022
- Published byĀ Springer NatureĀ inĀ Surgical Endoscopy
- Vol.Ā 36 Ā (8) , 5743-5752
Comparison of blue laser imaging and narrow band imaging for the differentiation of diminutive colorectal polyps: A randomized controlled trial
Background To compare the diagnostic efficacy of blue laser imaging (BLI)- bright and narrow band imaging (NBI) modes of image enhanced endoscopy (IEE) in differentiating neoplastic and non-neoplastic lesions of diminutive colorectal polyps. Methods We conducted a prospective randomized controlled trial from September 2015 to July 2016. The participants were randomly assigned (1:1) for colonoscopy with polyp classification under NBI or BLI-bright mode without magnification. Histopathologic diagnosis was used as the gold standard. Results Three hundred and twenty-four diminutive polyps in 164 patients were included for analysis (BLI: 162 polyps in 73 patients, NBI: 162 polyps in 91 patients). These polyps were located at colon proximal to sigmoid (61.1 and 58.0%) and rectosigmoid colon (38.9 and 42.0%) in the BLI and NBI groups, respectively. Most polyps (71.9%) were adenomatous with one malignant polyp (0.3%). BLI achieved 86.4% accuracy, 98.3% sensitivity, 55.6% specificity, 85.2% positive predictive value (PPV), and 92.6% negative predictive value (NPV), similar to NBI which exhibited 90.1% accuracy, 99.1% sensitivity, 67.4% specificity, 88.5% PPV, and 96.9% NPV in the diagnosis of adenomatous polyps. Based on the location of the polyp, both modes of IEE provided ā„ 95% NPV for diagnosis of adenomatous polyps at the rectosigmoid colon. Conclusions BLI-bright and NBI modes of IEE have similar accuracy in differentiation between neoplastic and non-neoplastic lesions of diminutive polyps. Both modes provided ā„ 90% NPV which allows for the adaptation of the American Society of Gastrointestinal Endoscopy ādiagnose-and-leaveā recommended strategy for diminutive polyps at the rectosigmoid colon.
- 26 January 2022
- Published byĀ Georg Thieme Verlag KGĀ inĀ Endoscopy
- Vol.Ā 54 Ā (11) , E624-E625
Endoscopic management of small bowel obstruction caused by intragastric balloon using antegrade single-balloon enteroscopy
A 44-year old woman with type 2 diabetes mellitus who underwent intragastric balloon (Spatz3) insertion 1 year ago presented with acute abdominal pain for 3 days. Abdominal examination showed mild tenderness at the epigastrium. Laboratory investigation showed a white blood cell count of 12,630 /mm3. An abdominal computed tomography (CT) scan revealed a distally migrated intragastric balloon in the mid-jejunum causing a small bowel obstruction ([Fig. 1]). After a discussion regarding treatment options, she decided to undergo endoscopic removal using antegrade single balloon-assisted enteroscopy. On endoscopy, an intragastric balloon filled with methylene blue completely occupied the jejunal lumen ([Fig. 2]). Duodenal and proximal jejunal mucosa, especially the surrounding area, was markedly inflamed and covered with exudates ([Fig. 3], [Fig. 4]). The balloon was punctured with a 25G needle, aspirated until completely collapsed, and then retrieved using a polypectomy snare ([Video 1], [Fig. 5]). A broad-spectrum intravenous antibiotic was given post-procedure. She was able to advance her diet and was safely discharged after hospitalization for 3 days. Video 1 Removal of the migrated intragastric balloon using antegrade single balloon-assisted enteroscopy. Intragastric balloon insertion is a minimally invasive and effective procedure with favorable safety profiles. Migration of an intragastric balloon occurred in approximately one percent of cases whereas 0.3 percent had an intestinal obstruction [1]. The risk of spontaneous balloon deflation and possible subsequent migration increases over time, especially after 6 months [2]. An intragastric balloon causing obstruction in the proximal duodenum is likely to be successfully removed endoscopically, whereas more distal migrations have been successfully treated laparoscopically, with few reports of percutaneous aspiration [2] [3]. At present, only two cases of successful endoscopic treatment of a migrated intragastric balloon using double balloon-assisted enteroscopy have been reported [4] [5]. We reported the first experience using antegrade single-balloon enteroscopy to a remove a migrated intragastric balloon. Meticulous care should be taken while gently withdrawing the scope with the attached balloon tightly grasped. Trauma to surrounding inflamed mucosa should be kept to a minimum. Endoscopy_UCTN_Code_CPL_1AH_2AJ Publication Date: 26 January 2022 (online) Ā© 2022. Thieme. All rights reserved. Georg Thieme Verlag KG RüdigerstraĆe 14, 70469 Stuttgart, Germany
- 26 January 2022
- Published byĀ Georg Thieme Verlag KGĀ inĀ Endoscopy
- Vol.Ā 54 Ā (11) , E624-E625
Endoscopic management of small bowel obstruction caused by intragastric balloon using antegrade single-balloon enteroscopy
A 44-year old woman with type 2 diabetes mellitus who underwent intragastric balloon (Spatz3) insertion 1 year ago presented with acute abdominal pain for 3 days. Abdominal examination showed mild tenderness at the epigastrium. Laboratory investigation showed a white blood cell count of 12,630 /mm3. An abdominal computed tomography (CT) scan revealed a distally migrated intragastric balloon in the mid-jejunum causing a small bowel obstruction ([Fig. 1]). After a discussion regarding treatment options, she decided to undergo endoscopic removal using antegrade single balloon-assisted enteroscopy. On endoscopy, an intragastric balloon filled with methylene blue completely occupied the jejunal lumen ([Fig. 2]). Duodenal and proximal jejunal mucosa, especially the surrounding area, was markedly inflamed and covered with exudates ([Fig. 3], [Fig. 4]). The balloon was punctured with a 25G needle, aspirated until completely collapsed, and then retrieved using a polypectomy snare ([Video 1], [Fig. 5]). A broad-spectrum intravenous antibiotic was given post-procedure. She was able to advance her diet and was safely discharged after hospitalization for 3 days. Video 1 Removal of the migrated intragastric balloon using antegrade single balloon-assisted enteroscopy. Intragastric balloon insertion is a minimally invasive and effective procedure with favorable safety profiles. Migration of an intragastric balloon occurred in approximately one percent of cases whereas 0.3 percent had an intestinal obstruction [1]. The risk of spontaneous balloon deflation and possible subsequent migration increases over time, especially after 6 months [2]. An intragastric balloon causing obstruction in the proximal duodenum is likely to be successfully removed endoscopically, whereas more distal migrations have been successfully treated laparoscopically, with few reports of percutaneous aspiration [2] [3]. At present, only two cases of successful endoscopic treatment of a migrated intragastric balloon using double balloon-assisted enteroscopy have been reported [4] [5]. We reported the first experience using antegrade single-balloon enteroscopy to a remove a migrated intragastric balloon. Meticulous care should be taken while gently withdrawing the scope with the attached balloon tightly grasped. Trauma to surrounding inflamed mucosa should be kept to a minimum. Endoscopy_UCTN_Code_CPL_1AH_2AJ Publication Date: 26 January 2022 (online) Ā© 2022. Thieme. All rights reserved. Georg Thieme Verlag KG RüdigerstraĆe 14, 70469 Stuttgart, Germany
- Open Access
- 30 March 2021
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 54 Ā (2) , 211-221
Prospective Comparison of the AIMS65 Score, Glasgow-Blatchford Score, and Rockall Score for Predicting Clinical Outcomes in Patients with Variceal and Nonvariceal Upper Gastrointestinal Bleeding
This study aimed to determine the performance of the AIMS65 score (AIMS65), Glasgow-Blatchford score (GBS), and Rockall score (RS) in predicting outcomes in patients with upper gastrointestinal bleeding (UGIB), and to compare the results between patients with nonvariceal UGIB (NVUGIB) and those with variceal UGIB (VUGIB). We conducted a prospective observational study between March 2016 and December 2017. Receiver operating characteristic curve analysis was performed for all outcomes for comparison. The associations of all three scores with mortality were evaluated using multivariate logistic regression analysis. Of the total of 337 patients with UGIB, 267 patients (79.2%) had NVUGIB. AIMS65 was significantly associated (odds ratio [OR]=1.735; 95% confidence interval [CI]=1.148-2.620), RS was marginally associated (OR=1.225; 95% CI=0.973-1.543), but GBS was not associated (OR=1.017; 95% CI=0.890-1.163) with mortality risk in patients with UGIB. However, all three scores accurately predicted all other outcomes (all p0.05). Only AIMS65 precisely predicted mortality, the need for blood transfusion and the composite endpoint (all p<0.05) in patients with VUGIB. AIMS65 is superior to GBS and RS in predicting mortality in patients with UGIB, and also precisely predicts the need for blood transfusion and the composite endpoint in patients with VUGIB. No scoring system could satisfactorily predict rebleeding in all patients with UGIB.
- 30 March 2021
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 54 Ā (2) , 211-221
Open AccessProspective Comparison of the AIMS65 Score, Glasgow-Blatchford Score, and Rockall Score for Predicting Clinical Outcomes in Patients with Variceal and Nonvariceal Upper Gastrointestinal Bleeding
This study aimed to determine the performance of the AIMS65 score (AIMS65), Glasgow-Blatchford score (GBS), and Rockall score (RS) in predicting outcomes in patients with upper gastrointestinal bleeding (UGIB), and to compare the results between patients with nonvariceal UGIB (NVUGIB) and those with variceal UGIB (VUGIB). We conducted a prospective observational study between March 2016 and December 2017. Receiver operating characteristic curve analysis was performed for all outcomes for comparison. The associations of all three scores with mortality were evaluated using multivariate logistic regression analysis. Of the total of 337 patients with UGIB, 267 patients (79.2%) had NVUGIB. AIMS65 was significantly associated (odds ratio [OR]=1.735; 95% confidence interval [CI]=1.148-2.620), RS was marginally associated (OR=1.225; 95% CI=0.973-1.543), but GBS was not associated (OR=1.017; 95% CI=0.890-1.163) with mortality risk in patients with UGIB. However, all three scores accurately predicted all other outcomes (all p0.05). Only AIMS65 precisely predicted mortality, the need for blood transfusion and the composite endpoint (all p<0.05) in patients with VUGIB. AIMS65 is superior to GBS and RS in predicting mortality in patients with UGIB, and also precisely predicts the need for blood transfusion and the composite endpoint in patients with VUGIB. No scoring system could satisfactorily predict rebleeding in all patients with UGIB.
- 24 February 2021
- Published byĀ Springer NatureĀ inĀ Surgical Endoscopy
- Vol.Ā 36 Ā (2) , 1-6
Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant biliary obstruction: the first case series
Background EUS-guided hepaticoesophagostomy (EUS-HES) was reported as an alternative procedure when puncture through the esophagus was inevitable. However, the existing data is very limited. We aimed to evaluate the efficacy and safety of EUS-HES in patients with difficult malignant biliary obstruction. Methods All cases who underwent EUS-HES at our institute were retrospectively reviewed. Results A total of 11 patients underwent EUS-HES from January 2011 to December 2017. Five were male, and the mean age was 57.9 ± 6.3 years. The majority of the patients (8 out of 11 patients) had a biliary obstruction caused by cholangiocarcinoma. The technical success was 100%. The mean procedure time was 73.2 ± 37.6 min. The main reason for EUS-HES was the improper alignment of the bile duct due to left lobe hypertrophy. The clinical success was 90.9%. The mean overall survival was 97.8 ± 68.5 days. No major procedure-related complication, particularly pneumomediastinum, occurred. Conclusions EUS-HES is a technically feasible and safe procedure to provide biliary drainage, especially in patients with left hepatic lobe hypertrophy. Using a bougie dilator instead of balloon dilation can avoid previously reported complications.
- 24 February 2021
- Published byĀ Springer NatureĀ inĀ Surgical Endoscopy
- Vol.Ā 36 Ā (2) , 1-6
Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant biliary obstruction: the first case series
Background EUS-guided hepaticoesophagostomy (EUS-HES) was reported as an alternative procedure when puncture through the esophagus was inevitable. However, the existing data is very limited. We aimed to evaluate the efficacy and safety of EUS-HES in patients with difficult malignant biliary obstruction. Methods All cases who underwent EUS-HES at our institute were retrospectively reviewed. Results A total of 11 patients underwent EUS-HES from January 2011 to December 2017. Five were male, and the mean age was 57.9 ± 6.3 years. The majority of the patients (8 out of 11 patients) had a biliary obstruction caused by cholangiocarcinoma. The technical success was 100%. The mean procedure time was 73.2 ± 37.6 min. The main reason for EUS-HES was the improper alignment of the bile duct due to left lobe hypertrophy. The clinical success was 90.9%. The mean overall survival was 97.8 ± 68.5 days. No major procedure-related complication, particularly pneumomediastinum, occurred. Conclusions EUS-HES is a technically feasible and safe procedure to provide biliary drainage, especially in patients with left hepatic lobe hypertrophy. Using a bougie dilator instead of balloon dilation can avoid previously reported complications.
- Open Access
- 11 December 2020
- Published byĀ Springer NatureĀ inĀ BMC Gastroenterology
- Vol.Ā 20 Ā (1) , 1-5
Immunoglobulin G4-associated autoimmune hepatitis with peripheral blood eosinophilia: a case report
Immunoglobulin G4 (IgG4) associated autoimmune hepatitis (AIH) has been recognized as a type of autoimmune disease that responds to corticosteroid. The diagnosis is based on elevation of the serum IgG4 level, abundance of IgG4 enhanced plasma cell infiltration in the portal region of the liver, and satisfaction of the criteria for ādefinite AIHā under the revised International Autoimmune Hepatitis Group (IAIHG) scoring system. However, the clinical course of the disease is unclear. A 65-year-old man with jaundice and peripheral blood eosinophilia. His IAIHG and simplified score was compatible with definite AIH and his IgG4 level was elevated. Magnetic resonance imaging did not reveal abnormalities in the hepatobiliary system or pancreas. A liver biopsy revealed interface hepatitis with IgG4 positive plasma cell infiltration in the portal region, without evidence of bile duct injury. He responded to 4-week period of induction prednisolone therapy and had no recurring symptoms under maintenance therapy of 5 mg prednisolone during the 3-year follow up. This was a rare case that demonstrated an association between IgG4 associated AIH and the presence of peripheral blood eosinophilia.
- 11 December 2020
- Published byĀ Springer NatureĀ inĀ BMC Gastroenterology
- Vol.Ā 20 Ā (1) , 1-5
Open AccessImmunoglobulin G4-associated autoimmune hepatitis with peripheral blood eosinophilia: a case report
Immunoglobulin G4 (IgG4) associated autoimmune hepatitis (AIH) has been recognized as a type of autoimmune disease that responds to corticosteroid. The diagnosis is based on elevation of the serum IgG4 level, abundance of IgG4 enhanced plasma cell infiltration in the portal region of the liver, and satisfaction of the criteria for ādefinite AIHā under the revised International Autoimmune Hepatitis Group (IAIHG) scoring system. However, the clinical course of the disease is unclear. A 65-year-old man with jaundice and peripheral blood eosinophilia. His IAIHG and simplified score was compatible with definite AIH and his IgG4 level was elevated. Magnetic resonance imaging did not reveal abnormalities in the hepatobiliary system or pancreas. A liver biopsy revealed interface hepatitis with IgG4 positive plasma cell infiltration in the portal region, without evidence of bile duct injury. He responded to 4-week period of induction prednisolone therapy and had no recurring symptoms under maintenance therapy of 5 mg prednisolone during the 3-year follow up. This was a rare case that demonstrated an association between IgG4 associated AIH and the presence of peripheral blood eosinophilia.